Why Muscle Monitoring Matters More Than Ever: Lessons from AMI and Myontec EMG in Knee Rehabilitation

Rehabilitation after a knee injury like ACL has always been a race against time, biology, and biomechanics. But new clinical studies reminds us of a critical truth: what you cannot activate, you cannot strengthen. Without proper muscle activation, especially in the quadriceps and surrounding stabilizing muscles, the risk of slow recovery or even re-injury increases dramatically.

An year old multicenter study from the SANTI Study Group (Saithna et al., 2024) confirms just how widespread this problem is. The findings shine a spotlight on Arthrogenic Muscle Inhibition (AMI) a neurological shutdown of the muscles surrounding the knee that can severely delay rehab and compromise outcomes. Recent study (Forelli et al., 2025) emphasis that even months to years after surgery, many athletes show persistent quadriceps inhibition, muscle-strength asymmetries, altered biomechanics, and elevated re-injury risk.

This is where Myontec products become an essential tool, not only in the return-to-sport period but also in early rehabilitation phase.

What the Research Shows: AMI Is Shockingly Common

SANTI Study Group analyzed 300 consecutive acute ACL injuries and found that:

• 56.7% of patients showed clear signs of AMI at their first clinical visit

• AMI caused quadriceps activation failure, extension deficits, and altered neuromuscular patterns

• Patients with AMI had significantly worse function scores (Lysholm, IKDC, KOOS) than those without it

• Key risk factors included:

  • Joint effusion

  • High pain scores

  • Use of crutches

  • Multi-ligament injuries

Why AMI Matters: Activation Failure Changes Everything

AMI prevents the quadriceps, especially the Vastus Medialis from firing normally.

As shown in the infographic, swelling and pain disrupt sensory feedback, alter spinal reflex pathways, reduce motor neuron excitability, and increase hamstring reflex activation.

Translation: patients lose their ability to properly activate key stabilizing muscles, even during simple movements.

If clinicians cannot see how muscles activate during exercises, it becomes guesswork. And guesswork is not sufficient for modern sports medicine.

Where Myontec Technology Changes the Game

Myontec products allow clinicians, physiotherapists, and athletes to see inside the movement, objectively, in real time. With precise EMG-based muscle activation tracking, Myontec technology helps you:

1. Detect inadequate muscle activation early

AMI causes quadriceps shutdown. Myontec provides immediate visibility into activation levels during basic exercises such as:

• Quad sets

• Straight-leg raises

• Mini-squats

• Step-ups

This ensures the athlete is not unknowingly reinforcing dysfunctional patterns.

2. Monitor load distribution and asymmetry

Even after AMI is reduced, athletes frequently compensate with:

• Excess hamstring activation

• Hip-dominant patterns

• Inadequate quadriceps engagement

Myontec shows these compensation patterns live during training, enabling targeted correction.

3. Guide individualized progression

Because Myontec quantifies muscle work, clinicians can:

• Progress exercises when activation meets criteria

• Detect lingering inhibition before it becomes chronic

• Reduce the risk of extension deficit and persistent weakness

• Optimize post-surgery electric muscle stimulation (EMS) treatment

This aligns with the study’s observation that AMI is often reversible early with the right targeted exercises.

4. Prevent re-injury during return-to-sport

The return-to-sport phase is where the stakes are highest. This is when:

• Load spikes

• Fatigue sets in

• Athletes revert to protective patterns

• Asymmetry quietly increases injury risk

Myontec MShorts provide objective load data in sport specific training so coaches and clinicians can:

• Compare left vs. right limb activation, as well as hamstring compensation and back chain

• Identify overloading or underuse

• Track the load and training intensity of sport-specific drills

• Ensure neuromuscular readiness, not just subjective readiness

Compromised neuromuscular control correlates with poorer clinical outcomes.

Why Return-to-Sport Decisions Need EMG, Not Just Strength Tests

Traditional return-to-sport tests are based on:

• Hop tests

• Isokinetic strength testing

• Movement assessments

But none of these reveal how the athlete is producing movement. An athlete can pass functional tests yet still:

• Under-activate the quadriceps

• Over-use hamstrings

• Compensate with the hip

• Exhibit hidden asymmetries

These hidden neuromuscular deficits are exactly what Myontec is built to uncover.

Given the high recurrence of ACL injuries, objective EMG data is no longer optional. It is essential.

Myontec + Evidence = Better Rehabilitation

The SANTI study reinforces what clinicians have long suspected:

👣 Neuromuscular activation, not just strength, determines recovery quality.

🧠 AMI is common, impactful, and requires targeted treatment.

📉 Failure to recognize AMI leads to prolonged deficits and worse outcomes.

By integrating Myontec technology into early-phase rehab and return-to-sport monitoring, practitioners gain a powerful advantage:

• Objective measurement

• Data-driven decisions

• Early detection of inhibition

• Safer progression

• Personalized, optimized and fasten rehabilitation

• Reduced re-injury risk

  
  

In short: what you can measure, you can improve.

Mbody3 Kit Legs

€939.00

Buy Now

The Future of ACL Rehab Is Objective and Muscle-Driven

The latest science shows that muscle activation quality, not only strength, defines knee rehabilitation success. Even if gross strength returns, neuromuscular control might not - implying increased risk of re-injury or suboptimal function. AMI affects over half of ACL injuries, and ignoring it can derail recovery.

Myontec technology empowers clinicians and athletes with real-time insights into the one thing that determines functional recovery: how the muscles actually work.

Without continuous neuromuscular monitoring, standard strength tests may paint a misleadingly optimistic picture. The time for subjective observation is over. The time for smart, objective, EMG-driven rehabilitation is here.

Referred studies

Saithna A et al. Incidence and Risk factors for Arthrogenic Muscle Inhibition (AMI) in Acute Anterior Cruciate Ligament Injuries. A Cross Sectional Study and Analysis of Associated Factors From the SANTI Study Group, 2024

Forelli F. et. al. Rethinking the Assessment of Arthrogenic Muscle Inhibition After ACL Reconstruction: Implications for Return-to-Sport Decision-Making - A Narrative Review, 2025

McPherson A. et al., Arthrogenic muscle inhibition after anterior cruciate ligament injury: Injured and uninjured limb recovery over time, 2023